(Q57482620)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18670773%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

title

Guidelines for radioiodine therapy of differentiated thyroid cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18670773%20AND%20SRC:MED&resulttype=core&format=json

differentiated thyroid carcinoma

11 January 2020

main subject

1 reference

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18670773%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

Wim Oyen

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18670773%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

author name string

M Luster

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18670773%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

S E Clarke

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18670773%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

M Dietlein

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18670773%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

P Lind

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18670773%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

J Tennvall

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18670773%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

E Bombardieri

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18670773%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

European Association of Nuclear Medicine (EANM)

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18670773%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

publication date

1 October 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18670773%20AND%20SRC:MED&resulttype=core&format=json

European Journal of Nuclear Medicine and Molecular Imaging

11 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18670773%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

volume

35

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18670773%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

issue

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18670773%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

page(s)

1941-1959

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18670773%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s00259-008-0883-1

11 January 2020

exact match

0 references

cites work

Quality-of-life changes in patients with thyroid cancer after withdrawal of thyroid hormone therapy.

1 reference

12 December 2020

Thyroid stunning in vivo and in vitro

1 reference

12 December 2020

124I-PET dosimetry in advanced differentiated thyroid cancer: therapeutic impact.

1 reference

12 December 2020

A comparison of 1850 (50 mCi) and 3700 MBq (100 mCi) 131-iodine administered doses for recombinant thyrotropin-stimulated postoperative thyroid remnant ablation in differentiated thyroid cancer

1 reference

12 December 2020

Iodine biokinetics and dosimetry in radioiodine therapy of thyroid cancer: procedures and results of a prospective international controlled study of ablation after rhTSH or hormone withdrawal

1 reference

12 December 2020

Thyroid hormone withdrawal in patients with differentiated thyroid carcinoma: a one hundred thirty-patient pilot survey on consequences of hypothyroidism and a pharmacoeconomic comparison to recombinant thyrotropin administration

1 reference

12 December 2020

Length and cost of hospital stay of radioiodine ablation in thyroid cancer patients: comparison between preparation with thyroid hormone withdrawal and thyrogen

1 reference

12 December 2020

Relation between effective radiation dose and outcome of radioiodine therapy for thyroid cancer

1 reference

12 December 2020

Impact of 131I-SPECT/CT images obtained with an integrated system in the follow-up of patients with thyroid carcinoma

1 reference

12 December 2020

Outcome of 309 patients with metastatic differentiated thyroid carcinoma treated with radioiodine

1 reference

12 December 2020

[Treatment and follow up protocol in differentiated thyroid carcinomas of follicular origin]

1 reference

12 December 2020

The effects of thyroid hormones on circulating markers of cell-mediated immune response, as studied in patients with differentiated thyroid carcinoma before and during thyroxine withdrawal.

1 reference

12 December 2020

Radioactive Iodine and the Salivary Glands

1 reference

12 December 2020

Comparison between remnant and red-marrow absorbed dose in thyroid cancer patients submitted to 131I ablative therapy after rh-TSH stimulation versus hypothyroidism induced by L-thyroxine withdrawal.

1 reference

12 December 2020

Effects of thyroid hormones on serum levels of adipokines as studied in patients with differentiated thyroid carcinoma during thyroxine withdrawal.

1 reference

12 December 2020

New therapeutic approaches for metastatic thyroid carcinoma

1 reference

12 December 2020

[Procedure guidelines for radioiodine therapy of differentiated thyroid cancer (version 3)]

1 reference

12 December 2020

Second primary cancers in thyroid cancer patients: a multinational record linkage study

1 reference

12 December 2020

Clinical impact of retinoids in redifferentiation therapy of advanced thyroid cancer: final results of a pilot study

1 reference

12 December 2020

Consequences of inadvertent radioiodine treatment of Graves’ disease and thyroid cancer in undiagnosed pregnancy. Can we rely on routine pregnancy testing?

1 reference

12 December 2020

Radioiodine-131 in the diagnosis and treatment of metastatic well differentiated thyroid cancer

1 reference

12 December 2020

Redifferentiation therapy in advanced thyroid cancer

1 reference

12 December 2020

Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer

1 reference

12 December 2020

Evaluation of dosimetry of radioiodine therapy in benign and malignant thyroid disorders by means of iodine-124 and PET

1 reference

12 December 2020

A comparison of short-term changes in health-related quality of life in thyroid carcinoma patients undergoing diagnostic evaluation with recombinant human thyrotropin compared with thyroid hormone withdrawal

1 reference

12 December 2020

Prognosis and treatment of brain metastases in thyroid carcinoma.

1 reference

12 December 2020

[Guideline 'Differentiated thyroid carcinoma', including diagnosis of thyroid nodules]

1 reference

12 December 2020

Comparison of Administration of Recombinant Human Thyrotropin with Withdrawal of Thyroid Hormone for Radioactive Iodine Scanning in Patients with Thyroid Carcinoma

1 reference

12 December 2020

Papillary and follicular thyroid carcinoma

1 reference

12 December 2020

rhTSH-aided radioiodine ablation and treatment of differentiated thyroid carcinoma: a comprehensive review.

1 reference

12 December 2020

Lung dosimetry for radioiodine treatment planning in the case of diffuse lung metastases.

1 reference

12 December 2020

Tumour dosimetry and response in patients with metastatic differentiated thyroid cancer using recombinant human thyrotropin before radioiodine therapy

1 reference

12 December 2020

Recombinant human thyroid-stimulating hormone is effective for radioiodine ablation of post-surgical thyroid remnants

1 reference

12 December 2020

Predictive estimate of blood dose from external counting data preceding radioiodine therapy for thyroid cancer

1 reference

12 December 2020

Empiric radioactive iodine dosing regimens frequently exceed maximum tolerated activity levels in elderly patients with thyroid cancer.

1 reference

12 December 2020

Leukaemias and cancers following iodine-131 administration for thyroid cancer

1 reference

12 December 2020

Preparation of patients with thyroid cancer for 131I scintigraphy or therapy by 1-3 weeks of thyroxine discontinuation

1 reference

12 December 2020

Regulation of the sodium/iodide symporter by retinoids--a review

1 reference

12 December 2020

Effects of low-iodide diet on postsurgical radioiodide ablation therapy in patients with differentiated thyroid carcinoma

1 reference

12 December 2020

Clinical review 128: Current approaches to primary therapy for papillary and follicular thyroid cancer

1 reference

12 December 2020

Papillary thyroid carcinoma managed at the Mayo Clinic during six decades (1940-1999): temporal trends in initial therapy and long-term outcome in 2444 consecutively treated patients

1 reference

12 December 2020

OLINDA/EXM: the second-generation personal computer software for internal dose assessment in nuclear medicine

1 reference

12 December 2020

"High-dose" radioiodine therapy in advanced differentiated thyroid carcinoma

1 reference

12 December 2020

A clinical study of all-trans-retinoid-induced differentiation therapy of advanced thyroid cancer.

1 reference

12 December 2020

131I therapy for differentiated thyroid cancer leads to an earlier onset of menopause: results of a retrospective study

1 reference

12 December 2020

Second primary malignancies in thyroid cancer patients

1 reference

12 December 2020

Exposure to radioactive iodine-131 for scintigraphy or therapy does not preclude pregnancy in thyroid cancer patients

1 reference

12 December 2020

Intensity-modulated radiation therapy for the treatment of nonanaplastic thyroid cancer

1 reference

12 December 2020

Management guidelines for patients with thyroid nodules and differentiated thyroid cancer

1 reference

12 December 2020

EANM Dosimetry Committee series on standard operational procedures for pre-therapeutic dosimetry I: blood and bone marrow dosimetry in differentiated thyroid cancer therapy.

1 reference

12 December 2020

[Procedure guideline for radioiodine test (Version 3)]

1 reference

12 December 2020

[Procedure guideline for radioiodine therapy and 131iodine whole-body scintigraphy in paediatric patients with differentiated thyroid cancer]

1 reference

12 December 2020

Survival and death causes in differentiated thyroid carcinoma.

1 reference

12 December 2020

Prediction of absorbed dose to normal organs in thyroid cancer patients treated with 131I by use of 124I PET and 3-dimensional internal dosimetry software.

1 reference

12 December 2020

The role of radioactive iodine in the treatment of Hürthle cell carcinoma of the thyroid

1 reference

12 December 2020

European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium

1 reference

12 December 2020

Long-term outcome of 444 patients with distant metastases from papillary and follicular thyroid carcinoma: benefits and limits of radioiodine therapy.

1 reference

12 December 2020

Low-dose hyper-radiosensitivity: a consequence of ineffective cell cycle arrest of radiation-damaged G2-phase cells.

1 reference

12 December 2020

External radiotherapy in thyroid cancers

1 reference

12 December 2020

Does lemon candy decrease salivary gland damage after radioiodine therapy for thyroid cancer?

1 reference

12 December 2020

Quality of life and psychometric functionality in patients with differentiated thyroid carcinoma.

1 reference

12 December 2020

The development of breast carcinoma in women with thyroid carcinoma

1 reference

12 December 2020

Real-time prognosis for metastatic thyroid carcinoma based on 2-[18F]fluoro-2-deoxy-D-glucose-positron emission tomography scanning

1 reference

12 December 2020

Occult thyroid carcinoma at autopsy in Malmö, Sweden

1 reference

12 December 2020

Cytotoxic effects of carboplatinum and epirubicin in the setting of an elevated serum thyrotropin for advanced poorly differentiated thyroid cancer

1 reference

12 December 2020

The role of external beam radiotherapy in the management of differentiated thyroid cancer

1 reference

12 December 2020

Thyroid carcinoma with high levels of function: treatment with (131)I.

1 reference

12 December 2020

Impact of 131I diagnostic activities on the biokinetics of thyroid remnants.

1 reference

12 December 2020

External-beam radiation therapy in the treatment of differentiated thyroid cancer

1 reference

12 December 2020

Survival and therapeutic modalities in patients with bone metastases of differentiated thyroid carcinomas

1 reference

12 December 2020

Pulmonary metastases in children and adolescents with well-differentiated thyroid cancer

1 reference

12 December 2020

Thyroid cancer: is the incidence still increasing?

1 reference

12 December 2020

Recombinant human thyrotropin-assisted radioiodine therapy for patients with metastatic thyroid cancer who could not elevate endogenous thyrotropin or be withdrawn from thyroxine

1 reference

12 December 2020

Natural history, diagnosis, treatment and outcome of papillary thyroid microcarcinoma (PTMC): a mono-institutional 12-year experience.

1 reference

12 December 2020

Testicular dose and fertility in men following I(131) therapy for thyroid cancer

1 reference

12 December 2020

Radioiodine-131 therapy for well-differentiated thyroid cancer--a quantitative radiation dosimetric approach: outcome and validation in 85 patients

1 reference

12 December 2020

Recombinant human TSH-assisted radioactive iodine remnant ablation achieves short-term clinical recurrence rates similar to those of traditional thyroid hormone withdrawal.

1 reference

12 December 2020

Role of surgery in treatment of advanced differentiated thyroid carcinomas

1 reference

12 December 2020

Papillary microcarcinoma of the thyroid-Prognostic significance of lymph node metastasis and multifocality

1 reference

12 December 2020

131I activity for remnant ablation in patients with differentiated thyroid cancer: A systematic review

1 reference

12 December 2020

Radioiodine treatment with 30 mCi after recombinant human thyrotropin stimulation in thyroid cancer: effectiveness for postsurgical remnants ablation and possible role of iodine content in L-thyroxine in the outcome of ablation

1 reference

12 December 2020

Comparison of radioiodine biokinetics following the administration of recombinant human thyroid stimulating hormone and after thyroid hormone withdrawal in thyroid carcinoma

1 reference

12 December 2020

Patient-specific dosimetry for 131I thyroid cancer therapy using 124I PET and 3-dimensional-internal dosimetry (3D-ID) software

1 reference

12 December 2020

A perspective on post-Chernobyl radioablation in young females.

1 reference

12 December 2020

Radioiodine ablation of thyroid remnants after preparation with recombinant human thyrotropin in differentiated thyroid carcinoma: results of an international, randomized, controlled study.

1 reference

12 December 2020

Clinical review 170: A systematic review and metaanalysis of the effectiveness of radioactive iodine remnant ablation for well-differentiated thyroid cancer

1 reference

12 December 2020

Iodine 131 treatment for differentiated thyroid carcinoma in patients with end stage renal failure: dosimetric, radiation safety, and practical considerations

1 reference

12 December 2020

Salivary gland toxicity after radioiodine therapy for thyroid cancer

1 reference

12 December 2020

Survival time and "cure" in papillary and follicular thyroid carcinoma with distant metastases: statistics following University of Michigan therapy

1 reference

12 December 2020

Bexarotene increases uptake of radioiodide in metastases of differentiated thyroid carcinoma

1 reference

12 December 2020

Testicular function after radioiodine therapy for thyroid carcinoma

1 reference

12 December 2020

The effect of 131 I therapy on survival of patients with metastatic papillary or follicular thyroid carcinoma

1 reference

12 December 2020

Acta Oncologica Lecture. Present status of the use of recombinant human TSH in thyroid cancer management.

1 reference

12 December 2020

Thyroid volume measurement in thyrotoxic patients: comparison between ultrasonography and iodine-124 positron emission tomography.

1 reference

12 December 2020

Subcutaneous administration of recombinant human thyrotropin as an alternative to thyroid hormone withdrawal in patients with anticoagulated thyroid cancer: preliminary results

1 reference

12 December 2020

The relation of radioiodine dosimetry to results and complications in the treatment of metastatic thyroid cancer

1 reference

12 December 2020

Hemodialysis of chronic kidney failure patients requiring ablative radioiodine therapy

1 reference

12 December 2020

External beam radiotherapy for differentiated thyroid cancer

1 reference

12 December 2020

MIRD pamphlet no. 16: Techniques for quantitative radiopharmaceutical biodistribution data acquisition and analysis for use in human radiation dose estimates

1 reference

12 December 2020

Quantitative imaging of iodine-124 with PET

1 reference

12 December 2020

A comparison of recombinant human thyrotropin and thyroid hormone withdrawal for the detection of thyroid remnant or cancer

1 reference

12 December 2020

Distant metastases in papillary thyroid carcinoma: 100 cases observed at one institution during 5 decades

1 reference

12 December 2020

Ablation of thyroid residues with 30 mCi (131)I: a comparison in thyroid cancer patients prepared with recombinant human TSH or thyroid hormone withdrawal

1 reference

12 December 2020

Different features of pulmonary metastases in differentiated thyroid cancer: natural history and multivariate statistical analysis of prognostic variables

1 reference

12 December 2020

Statistical methods applied to the diagnosis of hypothyroidism.

1 reference

12 December 2020

Children with differentiated thyroid cancer achieve adequate hyperthyrotropinemia within 14 days of levothyroxine withdrawal

1 reference

12 December 2020

Short-term hypothyroidism after Levothyroxine-withdrawal in patients with differentiated thyroid cancer: clinical and quality of life consequences

1 reference

12 December 2020

1 reference

12 December 2020

Targeted therapy in nuclear medicine--current status and future prospects.

1 reference

12 December 2020

Chronic thyrotropin-suppressive therapy with levothyroxine and short-term overt hypothyroidism after thyroxine withdrawal are associated with undesirable cardiovascular effects in patients with differentiated thyroid carcinoma.

1 reference

12 December 2020

Post-surgical use of radioiodine (131I) in patients with papillary and follicular thyroid cancer and the issue of remnant ablation: a consensus report

1 reference

12 December 2020

Sick leave for follow-up control in thyroid cancer patients: comparison between stimulation with Thyrogen and thyroid hormone withdrawal.

1 reference

12 December 2020

Thyroid disease and male reproductive function

1 reference

12 December 2020

Guidelines on radioiodine therapy for differentiated thyroid carcinoma: impact on clinical practice

1 reference

12 December 2020

Juvenile differentiated thyroid carcinoma and the role of radioiodine in its treatment: a qualitative review

1 reference

12 December 2020

A randomized trial of doxorubicin versus doxorubicin plus cisplatin in patients with advanced thyroid carcinoma.

1 reference

12 December 2020

Phase II evaluation of doxorubicin plus cisplatin in advanced thyroid cancer: a Southeastern Cancer Study Group Trial

1 reference

12 December 2020

Radioiodine ablation and therapy in differentiated thyroid cancer under stimulation with recombinant human thyroid-stimulating hormone

1 reference

12 December 2020

1 reference

12 December 2020

The role of postoperative external-beam radiotherapy in the management of patients with papillary thyroid cancer invading the trachea.

1 reference

12 December 2020

10.1007/S00259-008-0883-1

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18670773%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

1 reference